Cardiovascular

MicroPort® develops advanced technologies for interventional cardiology, combining innovation, clinical validation, and procedural performance. Our growing portfolio of drug-eluting stents and accessories supports physicians across a broad range of PCI procedures.

MicroPort®’s Vitaflow^® Aortic Valve, uses bovine pericardial leaflets to provide enhanced valve durability, its innovative frame and skirt designs deliver reliable hemodynamic performance, and dependable clinical outcomes for patients. Since launch, MicroPort®’s TAVR solution is fast becoming the leading therapeutic solution to treat aortic valve disease within China, and is currently expanding to more markets across the globe.